AES Corp/ US00130H1059 /
| 7/25/2024 4:18:22 PM | Chg. +0.08 | Volume | Bid4:18:22 PM | Ask4:18:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 17.39USD | +0.43% | 968,437 Turnover: 15.06 mill. |
17.38Bid Size: 1,000 | 17.39Ask Size: 900 | 12.32 bill.USD | 3.87% | 46.85 |
Newsfile Corp
7/17
Appia Announces Excellent Desorption Results From Target IV Ionic Adsorption Clay Rare Earth Mineral...
GlobeNewswire
7/1
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire
6/27
Brand Trust Is Higher for Utilities That Spend More on Communication and Highlight Savings and Envir...
GlobeNewswire
6/27
Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a N...
GlobeNewswire
6/26
AMERICAN SALARS SUBMITS SAMPLES FOR ASSAY FROM THE NEVADA BLACK ROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire
6/25
Tsecond and Carahsoft Partner to Bring Low SWaP, High-Performance Data Solutions for AI, Analytics a...
GlobeNewswire
6/25
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Tri...
GlobeNewswire
6/24
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel ...
GlobeNewswire
6/20
Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose ...
GlobeNewswire
6/20
Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for...
GlobeNewswire
6/20
Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potentia...
GlobeNewswire
6/18
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treat...
GlobeNewswire
6/18
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low ...
GlobeNewswire
6/17
2024 CSO Award Winners and Hall of Fame Inductees to be Recognized at the CSO Conference & Awards
GlobeNewswire
6/17
FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire
6/14
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire
6/14
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...
GlobeNewswire
6/13
Lantronix Wins 2024 IoT Evolution Asset Tracking Award for FOX3 Telematic Gateway
GlobeNewswire
6/12
NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at ...
